Ad is loading...
SUHIX
Price
$44.85
Change
-$0.97 (-2.12%)
Updated
Nov 15 closing price
VGHCX
Price
$204.50
Change
-$5.96 (-2.83%)
Updated
Nov 15 closing price
Ad is loading...

SUHIX vs VGHCX

Header iconSUHIX vs VGHCX Comparison
Open Charts SUHIX vs VGHCXBanner chart's image
DWS Health and Wellness Inst
Price$44.85
Change-$0.97 (-2.12%)
VolumeN/A
CapitalizationN/A
Vanguard Health Care I
Price$204.50
Change-$5.96 (-2.83%)
VolumeN/A
CapitalizationN/A
SUHIX vs VGHCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SUHIX vs. VGHCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SUHIX is a Sell and VGHCX is a Sell.

FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 45.7B vs. SUHIX (277M). VGHCX pays higher dividends than SUHIX: VGHCX (0.79) vs SUHIX (0.00). SUHIX was incepted earlier than VGHCX: SUHIX (24 years) vs VGHCX (41 years). SUHIX is a more actively managed with annual turnover of: 27.00 vs. VGHCX (16.00). VGHCX has a lower initial minimum investment than SUHIX: VGHCX (3000) vs SUHIX (1000000). SUHIX annual gain was more profitable for investors over the last year : 8.52 vs. VGHCX (1.65). SUHIX return over 5 years is better than : 6.88 vs. VGHCX (-2.73).
SUHIXVGHCXSUHIX / VGHCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years41 years-
Gain YTD6.507-2.205-295%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets277M45.7B1%
Annual Yield % from dividends0.000.79-
Returns for 1 year8.521.65518%
Returns for 3 years-7.00-13.8551%
Returns for 5 years6.88-2.73-253%
Returns for 10 years-0.88-9.949%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UDR44.31-0.24
-0.54%
UDR
EXTO3.91-0.02
-0.57%
Almacenes Exito SA
OI12.97-0.17
-1.29%
O-I Glass
VIRX0.15-0.01
-4.37%
Viracta Therapeutics
PEPG4.12-0.37
-8.24%
PepGen